ALRN NASDAQ
Aileron Therapeutics, Inc.
1W: +4.1%
1M: +0.0%
3M: -47.8%
1Y: -52.7%
3Y: -77.6%
5Y: -84.5%
$2.11
Last traded 2025-02-07 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
📊 Key Metrics
TTM$0M
Revenue
-100.0% YoY
$-50M
Net Income
+15.9% YoY
$-19M
Free Cash Flow
+11.3% YoY
0.0%
Gross Margin
0.0%
Op. Margin
0.0%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-96.4%
ROA-80.6%
ROIC-268.4%
Valuation
P/E-1.2
P/B2.6
EV/EBITDA-2.2
Leverage
Debt/Equity0.00
Current Ratio4.27
Interest Cov.0.0x
Quality Scores
Piotroski F3/9
Altman Z-0.19
Beneish M0.00